Chemomab Therapeutics Ltd. Increase (Decrease) in Other Deferred Liability
Chemomab Therapeutics Ltd. (CMMB) reported Increase (Decrease) in Other Deferred Liability of -$240.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherDeferredLiability · last filed 2021-03-09
- Chemomab Therapeutics Ltd. increase (decrease) in other deferred liability for fiscal 2020 was -$240.00K.
- Chemomab Therapeutics Ltd. increase (decrease) in other deferred liability for fiscal 2019 was -$1.00K, a 100.76% decline from fiscal 2018.
- Chemomab Therapeutics Ltd. increase (decrease) in other deferred liability for fiscal 2018 was $132.00K.
| Period end | Increase (Decrease) in Other Deferred Liability 12 month |
|---|---|
| 2020-12-31 | -$240.00K 10-K · filed 2021-03-09 |
| 2019-12-31 | -$1.00K 10-K · filed 2021-03-09 |
| 2018-12-31 | $132.00K 10-K · filed 2020-03-17 |